MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
PASG
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Passage Bio (PASG) Ownership - Who owns Passage Bio?

Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
2005 Market Street
Phone
+1 267 866-0311
Employees
24
Web
https://www.passagebio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
18.16M
P/E Ratio
0.03
Total Cash
33.34M
Projected Growth
N/A
Total Debt
5.76M
Revenue
N/A
Risk (Beta)
2.46
Dividend Yield
N/A
Total Cash/Share
10.39
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
PASG
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for PASG
A.I. Advisor
published General Information

General Information

a genetic medicines company, which focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options

Industry Biotechnology

Profile
Details
Industry
N/A
Address
2005 Market Street
Phone
+1 267 866-0311
Employees
24
Web
https://www.passagebio.com